1. Automated isolation of primary antigen‐specific T cells from donor lymphocyte concentrates: results of a feasibility exercise. Issue 4 (7th May 2015) Authors: Bunos, M.; Hümmer, C.; Wingenfeld, E.; Sorg, N.; Pfirrmann, V.; Bader, P.; Seifried, E.; Bönig, H. Journal: Vox sanguinis Issue: Volume 109:Issue 4(2015) Page Start: 387 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Bacterial contamination in platelet concentrates. (April 2014) Authors: Pietersz, R. N. I.; Reesink, H. W.; Panzer, S.; Oknaian, S.; Kuperman, S.; Gabriel, C.; Rapaille, A.; Lambermont, M.; Deneys, V.; Sondag, D.; Ramírez‐Arcos, S.; Goldman, M.; Delage, G.; Bernier, F.; Germain, M.; Vuk, T.; Georgsen, J.; Morel, P.; Naegelen, C.; Bardiaux, L. Journal: Vox sanguinis Issue: Volume 106:issue 3(2014) Page Start: 256 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Blood transfusion: one unit too much or one unit too few – which strategy poses the smallest risk to the patient?. (26th September 2017) Authors: Seifried, E.; Mueller, M. M. Journal: ISBT science series Issue: Volume 13:Number 1(2018) Page Start: 101 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Enlargement of the WHO international repository for platelet transfusion‐relevant bacteria reference strains. Issue 8 (27th September 2017) Authors: Spindler‐Raffel, E.; Benjamin, R. J.; McDonald, C. P.; Ramirez‐Arcos, S.; Aplin, K.; Bekeredjian‐Ding, I.; de Korte, D.; Gabriel, C.; Gathof, B.; Hanschmann, K.‐M.; Hourfar, K.; Ingram, C.; Jacobs, M. R.; Keil, S. D.; Kou, Y.; Lambrecht, B.; Marcelis, J.; Mukhtar, Z.; Nagumo, H.; Niekerk, T. Journal: Vox sanguinis Issue: Volume 112:Issue 8(2017) Page Start: 713 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Evaluation of two, commercial, multi‐dye, nucleic acid amplification technology tests, for HBV/HCV/HIV‐1/HIV‐2 and B19V/HAV, for screening blood and plasma for further manufacture. Issue 1 (1st August 2012) Authors: Müller, M. M.; Fraile, M. I. G.; Hourfar, M. K.; Peris, L. B.; Sireis, W.; Rubin, M. G.; López, E. M.; Rodriguez, G. T.; Seifried, E.; Saldanha, J.; Schmidt, M. Journal: Vox sanguinis Issue: Volume 104:Issue 1(2013) Page Start: 19 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Four amino acid exchanges located in the alpha‐2 domain specify the novel HLA‐B*50:20 allele. Issue 6 (December 2015) Authors: Becker, P. S. A.; Seifried, E.; Seidl, C. Journal: Tissue antigens Issue: Volume 86:Issue 6(2015) Page Start: 453 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Head‐to‐head comparison between two screening systems for HBsAG, anti‐HBc, anti‐HCV and HIV combination immunoassays in an international, multicentre evaluation study. Issue 2 (20th April 2015) Authors: Schmidt, M.; Jimenez, A.; Mühlbacher, A.; Oota, S.; Blanco, L.; Sakuldamrongpanich, T.; Schennach, H.; Seifried, E. Journal: Vox sanguinis Issue: Volume 109:Issue 2(2015) Page Start: 114 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Leucodepletion for hyperleucocytosis – first report on a novel technology featuring electronic interphase management. Issue 1 (6th February 2013) Authors: Schulz, M.; Bug, G.; Bialleck, H.; Serve, H.; Seifried, E.; Bönig, H. Journal: Vox sanguinis Issue: Volume 105:Issue 1(2013) Page Start: 47 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. New strategies for bacterial contaminations. (June 2016) Authors: Schmidt, M.; Seifried, E. Journal: ISBT science series Issue: Volume 11(2016)Supplement 2 Page Start: 137 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Next generation FIX muteins with FVIII‐independent activity for alternative treatment of hemophilia A. (15th October 2014) Authors: Quade‐Lyssy, P.; Abriss, D.; Milanov, P.; Ungerer, C.; Königs, C.; Seifried, E.; Schüttrumpf, J. Journal: Journal of thrombosis and haemostasis Issue: Volume 12:Number 11(2014:Nov.) Page Start: 1861 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗